03/24/2025 4:35 PM | Azamian Bobak R. (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025 8:49 PM | Mottiwala Aziz (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2025 8:48 PM | Farrow Jeffrey S (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2025 8:48 PM | Azamian Bobak R. (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2025 8:48 PM | Tarsus Pharmaceuticals (Issuer) Whitfield Dianne C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2025 8:49 PM | Tarsus Pharmaceuticals (Issuer) Wahl Bryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2025 8:49 PM | Neervannan Seshadri (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2025 3:29 PM | Mottiwala Aziz (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025 3:30 PM | Farrow Jeffrey S (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025 3:35 PM | Tarsus Pharmaceuticals (Subject) Whitfield Dianne C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025 3:18 PM | Neervannan Seshadri (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for TARS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
03/20/2025 3:21 PM | Tarsus Pharmaceuticals (Subject) Wahl Bryan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025 3:11 PM | Azamian Bobak R. (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 2:24 PM | Tarsus Pharmaceuticals (Subject) Wahl Bryan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 2:27 PM | Neervannan Seshadri (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 2:22 PM | Tarsus Pharmaceuticals (Subject) Whitfield Dianne C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 2:23 PM | Azamian Bobak R. (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 2:12 PM | Mottiwala Aziz (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025 2:12 PM | Farrow Jeffrey S (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025 8:38 PM | Mottiwala Aziz (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 8:39 PM | Neervannan Seshadri (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 8:39 PM | Tarsus Pharmaceuticals (Issuer) Wahl Bryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 8:39 PM | Tarsus Pharmaceuticals (Issuer) Whitfield Dianne C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 8:40 PM | Azamian Bobak R. (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 8:40 PM | Farrow Jeffrey S (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 3:26 PM | Mottiwala Aziz (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025 3:26 PM | Tarsus Pharmaceuticals (Subject) Wahl Bryan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025 3:31 PM | Neervannan Seshadri (Reporting) Tarsus Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025 3:20 PM | Tarsus Pharmaceuticals (Subject) Whitfield Dianne C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025 3:37 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
03/13/2025 3:40 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2025 3:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
03/07/2025 3:17 PM | Lin Elizabeth Yeu (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 3:17 PM | Azamian Bobak R. (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 3:18 PM | Tarsus Pharmaceuticals (Issuer) Wahl Bryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 3:19 PM | Neervannan Seshadri (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 3:19 PM | Mottiwala Aziz (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/25/2025 6:07 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2025 11:22 AM | Cowen Financial Products LLC (Filed by) Tarsus Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/17/2025 4:08 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/13/2025 7:30 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
A brutally honest economic warning for 2025 (see proof) (Ad) New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked side-by-side with figures like Warren Buffett, Alan Greenspan, Ron Paul, Jim Rickards, and Steve Forbes, to name but a few) says.... Full details here. |
12/19/2024 4:03 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 2:05 PM | Cormorant Asset Management, LP (Filed by) Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024 3:06 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2024 3:40 PM | Lin Elizabeth Yeu (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 9:26 AM | Frazier Life Sciences IX, L.P. (Filed by) Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/05/2024 3:06 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 1:00 PM | Tarsus Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/21/2024 3:11 PM | BlackRock, Inc. (Filed by) Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/02/2024 4:27 PM | Morrison Scott W (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 4:52 PM | Morrison Scott W (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 3:34 PM | LINK WILLIAM J PHD (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:21 PM | Tarsus Pharmaceuticals (Issuer) YARNO WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:22 PM | CHAUDHURI BHASKAR (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:23 PM | Morrison Scott W (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:24 PM | Lin Elizabeth Yeu (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:25 PM | LINK WILLIAM J PHD (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:26 PM | Goldberg Andrew D. (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:26 PM | Crane Rosemary A (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 4:44 PM | CHAUDHURI BHASKAR (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:45 PM | Goldberg Andrew D. (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:33 PM | Lin Elizabeth Yeu (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:38 PM | Tarsus Pharmaceuticals (Issuer) YARNO WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:40 PM | Crane Rosemary A (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:28 PM | LINK WILLIAM J PHD (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:30 PM | Morrison Scott W (Reporting) Tarsus Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 3:12 PM | Tarsus Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024 3:24 PM | Tarsus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/26/2024 3:25 PM | Tarsus Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024 7:34 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 1:56 PM | Tarsus Pharmaceuticals (Subject) Trevejo Jose M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024 1:06 PM | Tarsus Pharmaceuticals (Subject) Trevejo Jose M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |